ClinicalTrials.gov record
Completed Phase 2 Interventional

The Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Never Used Anti-HIV Drugs

ClinicalTrials.gov ID: NCT00001067

Public ClinicalTrials.gov record NCT00001067. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 7:17 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Randomized Study of the Virologic and Immunologic Effects of Zidovudine Plus Lamivudine (3TC) Versus d4T Versus Zidovudine Plus d4T in HIV-Infected Patients With CD4 Cell Counts Between 300-600/mm3 and No Previous Nucleoside Experience

Study identification

NCT ID
NCT00001067
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Enrollment
105 participants

Conditions and interventions

Conditions

Interventions

  • Lamivudine Drug
  • Stavudine Drug
  • Zidovudine Drug

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Oct 31, 1997
Last update posted
Oct 31, 2021

Ends 1997

United States locations

U.S. sites
12
U.S. states
9
U.S. cities
10
Facility City State ZIP Site status
Alabama Therapeutics CRS Birmingham Alabama 35294
Stanford CRS Palo Alto California 94305
Ucsd, Avrc Crs San Diego California 92103
Howard University Hosp., Div. of Infectious Diseases, ACTU Washington D.C. District of Columbia 20059
The Ponce de Leon Ctr. CRS Atlanta Georgia
Johns Hopkins Adult AIDS CRS Baltimore Maryland 21287
Washington U CRS St Louis Missouri 63110
St. Louis ConnectCare, Infectious Diseases Clinic St Louis Missouri 63112
Beth Israel Med. Ctr. (Mt. Sinai) New York New York 10003
NYU Med. Ctr., Dept. of Medicine New York New York 10016
Unc Aids Crs Chapel Hill North Carolina 27599
The Ohio State Univ. AIDS CRS Columbus Ohio 43210

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00001067, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 31, 2021 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00001067 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →